Mirahype S 50/5 Tablet ER
Mirahype S 50/5 Tablet ER
Mirabegron (50mg) + Solifenacin (5mg)
Mirago S 50 Combikit
Sun Pharmaceutical Industries Ltd
Solifenacin 5mg
Pack Size
1 units
Price
Save ₹132
that's 33% off!
About This Medicine
Product description & overview
Mirahype S 50/5 Tablet ER: A Powerful Combination for Overactive Bladder
Mirahype S 50/5 Tablet ER combines the effectiveness of mirabegron (50mg) with solifenacin (5mg), offering comprehensive relief for men and women experiencing overactive bladder (OAB). This extended-release tablet provides sustained action throughout the day, targeting both urgency and frequency symptoms.
Mirabegron is a selective beta3-adrenergic agonist that relaxes the detrusor muscle of the bladder, promoting urinary flow control. Solifenacin, a muscarinic receptor antagonist, reduces bladder contractions and improves bladder emptying.
The combined action of Mirahype S 50/5 Tablet ER helps manage OAB symptoms like:
* Frequent urination
* Urgent urination
* Leakage during urination
Mirahype S 50/5 Tablet ER is for adults with OAB who are seeking long-term relief. This medication should be taken only as prescribed by your healthcare provider. Always consult with a medical professional for individualized guidance regarding dosage and treatment options.
Note: This product description serves informational purposes only and does not constitute medical advice.
Active composition
Solifenacin 5 mg
+1 more active ingredient
About Solifenacin
Solifenacin is an antimuscarinic agent used to treat overactive bladder symptoms. It works by relaxing bladder muscles and reducing urgency. Solifenacin's clinical significance lies in its ability to improve bladder control. In summary, Solifenacin is beneficial for managing urinary incontinence.
How It Works
Solifenacin antagonizes muscarinic receptors in the bladder, reducing detrusor muscle contractions and increasing bladder capacity.
All Active Ingredients
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Mirahype S 50/5 Tablet ER during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Mirahype S 50/5 Tablet ER during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
There is limited information available on the use of Mirahype S 50/5 Tablet ER in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Mirahype S 50/5 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Mirahype S 50/5 Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Mirahype S 50/5 Tablet ER